Jane Street’s Trueblue TBI Stock Holding History

Jane Street’s Portfolio TBI Stock Details TBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-25,500	Closed	-$156K	–	12355
2025 Q3	$156K	Sell	25,500 -2,900	-10%	-$18.3K	﹤0.01%	9855
2025 Q2	$184K	Buy	+28,400	New	+$153K	﹤0.01%	8614

Other funds holding TBI

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

Azarias Capital Management Berwyn, Pennsylvania $230M AUM 39.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Jane Street's TBI Position: Q1 2026 in Review

Jane Street sold out of Trueblue (TBI) in Q1 2026, closing a stake of 16,266 shares — an estimated $74K sold.

Jane Street first reported a position in TBI in Q2 2013 and held it in 17 quarters. The position peaked at $4.92M in Q4 2023. 105 funds tracked by Wall St. Rank hold TBI as of Q1 2026.

Jane Street reported no remaining Trueblue position as of Q1 2026 after selling out during the quarter.
Jane Street sold 16,266 Trueblue shares in Q1 2026, an estimated $74K.
Jane Street first reported a position in Trueblue in Q2 2013 and held it in 17 quarters.
Jane Street's Trueblue position peaked at $4.92M in Q4 2023.
105 funds tracked by Wall St. Rank held Trueblue as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.